Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial

Yewande E. Odeyemi, Sarah J. Chalmers, Erin F. Barreto, Jacob C. Jentzer, Ognjen Gajic, Hemang Yadav

Research output: Contribution to journalLetterpeer-review

Abstract

ClinicalTrials.gov identifier (NCT number): NCT03852537, Registered February 25, 2019.

Original languageEnglish (US)
Article number9
JournalCritical Care
Volume26
Issue number1
DOIs
StatePublished - Dec 2022

Keywords

  • C-reactive protein
  • Coronavirus disease 2019
  • Corticosteroids

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial'. Together they form a unique fingerprint.

Cite this